Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies.

Rudek MA, Zhao M, He P, Zabelina Y, Jin R, Messersmith WA, Wolff AC, Baker SD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 15;828(1-2):41-54. Epub 2005 Oct 25.

PMID:
16253576
2.

A sensitive method for determination of COL-3, a chemically modified tetracycline, in human plasma using high-performance liquid chromatography and ultraviolet detection.

Rudek MA, Hartke C, Zabelina Y, Zhao M, New P, Baker SD.

J Pharm Biomed Anal. 2005 Apr 1;37(4):751-6. Epub 2004 Dec 29.

PMID:
15797797
3.

Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry.

Zhao M, Hartke C, Jimeno A, Li J, He P, Zabelina Y, Hidalgo M, Baker SD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 May 5;819(1):73-80.

PMID:
15797523
4.

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV.

Rudek MA, Zabelina Y, Zhao M, Wolff AC, Baker SD.

Biomed Chromatogr. 2004 Jun;18(5):282-7.

PMID:
15236435
5.

Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

Baker SD, Zhao M, Lee CK, Verweij J, Zabelina Y, Brahmer JR, Wolff AC, Sparreboom A, Carducci MA.

Clin Cancer Res. 2004 Mar 15;10(6):1976-83.

6.

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS.

Zhao M, Zabelina Y, Rudek MA, Wolff AC, Baker SD.

J Pharm Biomed Anal. 2003 Nov 24;33(4):725-33.

PMID:
14623599
7.

Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile.

Wolff AC, Donehower RC, Carducci MK, Carducci MA, Brahmer JR, Zabelina Y, Bradley MO, Anthony FH, Swindell CS, Witman PA, Webb NL, Baker SD.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3589-97.

8.

Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies.

Sparreboom A, Wolff AC, Verweij J, Zabelina Y, van Zomeren DM, McIntire GL, Swindell CS, Donehower RC, Baker SD.

Clin Cancer Res. 2003 Jan;9(1):151-9.

9.

Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer.

Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, Casero RA Jr.

Clin Cancer Res. 2002 Mar;8(3):684-90.

10.

A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.

Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, Zabelina Y, Chen TL, Grochow LB, Donehower RC.

Clin Cancer Res. 2001 Oct;7(10):3047-55.

11.

A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.

Gilbert J, Baker SD, Bowling MK, Grochow L, Figg WD, Zabelina Y, Donehower RC, Carducci MA.

Clin Cancer Res. 2001 Aug;7(8):2292-300.

Supplemental Content

Loading ...
Support Center